Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 32 clinical trials
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma

Background Diffuse large B-cell lymphoma is the most common type of non-Hodgkin lymphoma. Most people with this cancer can be cured. But those who are not cured have a poor prognosis. Researchers want to add another drug to standard treatment see if it can improve the cure rate. Objective To …

r-chop regimen
gilbert's syndrome
doxorubicin
prednisone
platelet count
  • 0 views
  • 27 Feb, 2021
  • 1 location
Pathogenesis of BTK-mediated Hyper-Inflammatory Responses in COVID-19 (RESPOND)

are in the hospital with COVID-19. They will or will not be treated with a BTK inhibitor. They do not have COVID-19. They are or are not in the hospital. They will be treated with a BTK

SARS
coronavirus infection
covid-19
  • 47 views
  • 26 Feb, 2021
  • 3 locations